1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA AP1S1 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA BAIAP2 CTRPv2 pan-cancer AAC 0.15 0.0002
mRNA MYL9 CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA GOT2 CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA KDR CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA FBXL6 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA SPRED1 CTRPv2 pan-cancer AAC 0.16 0.0002
mRNA CLN6 CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA RAP2B CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA AARS CTRPv2 pan-cancer AAC -0.13 0.0002
Download CSV